ATE262594T1 - Verfahren zur modulation der zell-apoptose - Google Patents

Verfahren zur modulation der zell-apoptose

Info

Publication number
ATE262594T1
ATE262594T1 AT96930710T AT96930710T ATE262594T1 AT E262594 T1 ATE262594 T1 AT E262594T1 AT 96930710 T AT96930710 T AT 96930710T AT 96930710 T AT96930710 T AT 96930710T AT E262594 T1 ATE262594 T1 AT E262594T1
Authority
AT
Austria
Prior art keywords
apoptosis
cell apoptosis
modulating cell
beta
inhibit
Prior art date
Application number
AT96930710T
Other languages
English (en)
Inventor
Damme Jo Van
Paul Proost
Frederic Houssiau
Jean-Christophe Renauld
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9518611.0A external-priority patent/GB9518611D0/en
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of ATE262594T1 publication Critical patent/ATE262594T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/523Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5412IL-6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT96930710T 1995-09-12 1996-09-04 Verfahren zur modulation der zell-apoptose ATE262594T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9518611.0A GB9518611D0 (en) 1995-09-12 1995-09-12 Anti-apoptotic factors
US08/541,905 US5824551A (en) 1995-09-12 1995-10-10 Method for modulating cell apoptosis
PCT/US1996/014239 WO1997010361A1 (en) 1995-09-12 1996-09-04 Method for modulating cell apoptosis

Publications (1)

Publication Number Publication Date
ATE262594T1 true ATE262594T1 (de) 2004-04-15

Family

ID=26307738

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96930710T ATE262594T1 (de) 1995-09-12 1996-09-04 Verfahren zur modulation der zell-apoptose

Country Status (7)

Country Link
EP (1) EP0850319B1 (de)
JP (1) JPH11513367A (de)
AT (1) ATE262594T1 (de)
AU (1) AU711011B2 (de)
CA (1) CA2231433A1 (de)
DE (1) DE69631962T2 (de)
WO (1) WO1997010361A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US9762685B2 (en) 2005-04-27 2017-09-12 Live Nation Entertainment, Inc. Location-based task execution for enhanced data access

Also Published As

Publication number Publication date
CA2231433A1 (en) 1997-03-20
AU6966596A (en) 1997-04-01
JPH11513367A (ja) 1999-11-16
EP0850319B1 (de) 2004-03-24
AU711011B2 (en) 1999-10-07
EP0850319A4 (de) 1998-08-05
WO1997010361A1 (en) 1997-03-20
DE69631962D1 (de) 2004-04-29
DE69631962T2 (de) 2005-04-07
EP0850319A1 (de) 1998-07-01

Similar Documents

Publication Publication Date Title
BR9710570A (pt) Inibidor de adesão de células
DE69933896D1 (de) Verfahren zur Aufrechterhaltung der Gleichförmigkeit von Farbmessgeräten
EE03694B1 (et) Rakuadhesiooni inhibiitorid, neid sisaldavad kompositsioonid ja nende kasutamine
DE69532188D1 (de) Flüssigkeit zur Beschichtung von Zähnen
DK199901519A (da) I form af små molekyler foreliggende inhibitorer af rotamase-enzymaktivitet
EE9900006A (et) Uued amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena
DE69719409D1 (de) Verfahren zur Reinigung von DNS
EE9700354A (et) Trombiini uued inhibiitorid, nende saamine ja kasutamine
DE69710479D1 (de) Organomineralgel zur dekontamination von oberflächen
EE9900600A (et) Uued amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena
DE69934305D1 (de) Verwendung von dexmedetomidine zur sedierung auf der intensivstation
ATE230034T1 (de) Verfahren zur aufreinigung von dns
DE69704189D1 (de) Verfahren zur Reinigung von Wasserstoffperoxid
DE59808699D1 (de) Verwendung von amphiphilen zur dauerhaften verbesserung der klebstoff- und/oder beschichtungs-kompatibilität von polyolefin-basierten formkörpern
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
DE59610713D1 (de) Elektrodenkatheter zur kartierenden erfassung von reizleitungsstrukturen
ATE262594T1 (de) Verfahren zur modulation der zell-apoptose
DE69937678D1 (de) Verfahren zur schnellen bestimmung von bakterien
DE69709884D1 (de) Verfahren zur auswertung der verschlechterung von isolierpapier
DE69920436D1 (de) Simulierte testverbindung zur untersuchung von drehschlagwerkzeugen
DE3669063D1 (de) Verfahren zur desinfektion von lokalen gegen kokkizide oozysten.
ATE305040T1 (de) Pge synthase und verfahren und mitteln zur modulation deren aktivität
DE59604894D1 (de) Testsystem zur erfassung der aktivität von nk-zellen
DE69941317D1 (de) Verfahren zur Untersuchung von Gasen
DE69725100D1 (de) Verfahren und Satz zur Prüfung der Drogenempfindlichkeit von Mikroben, sowie Verfahren und Satz zur Missung der minimumhemmenden Konzentration von Mikroorganismen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties